ESSINGTON CLINIC LIMITED

Company Registration Number:
04887462 (England and Wales)

Unaudited statutory accounts for the year ended 31 December 2023

Period of accounts

Start date: 01 January 2023

End date: 31 December 2023

ESSINGTON CLINIC LIMITED

Contents of the Financial Statements

for the Period Ended 31 December 2023

Company Information - 3
Balance sheet - 4
Additional notes - 6
Balance sheet notes - 9

ESSINGTON CLINIC LIMITED

Company Information

for the Period Ended 31 December 2023




Director: Mr B L Parsons
Mrs T L Parsons
Mr Z C Cole
Ms P O Antrobus
Mr D T Antrobus
Mr D H Antrobus
Mr M G Antrobus
Mr O M Antrobus
Registered office: 132
Birmingham Road
Lichfield
England
WS14 9BW
Company Registration Number: 04887462 (England and Wales)

ESSINGTON CLINIC LIMITED

Balance sheet

As at 31 December 2023


Notes

2023
£

2022
£
Fixed assets
Intangible assets: 4 0 0
Tangible assets: 5 4,260 7,196
Total fixed assets: 4,260 7,196
Current assets
Stocks: 750 1,500
Debtors: 6 40,118 0
Cash at bank and in hand: 12,058 40,255
Total current assets: 52,926 41,755
Creditors: amounts falling due within one year: 7 ( 23,947 ) ( 16,246 )
Net current assets (liabilities): 28,979 25,509
Total assets less current liabilities: 33,239 32,705
Creditors: amounts falling due after more than one year: 8 ( 11,774 ) ( 19,239 )
Provision for liabilities: ( 809 ) ( 1,367 )
Total net assets (liabilities): 20,656 12,099

The notes form part of these financial statements

ESSINGTON CLINIC LIMITED

Balance sheet continued

As at 31 December 2023


Notes

2023
£

2022
£
Capital and reserves
Called up share capital: 100 100
Profit and loss account: 20,556 11,999
Shareholders funds: 20,656 12,099

For the year ending 31 December 2023 the company was entitled to exemption under section 477 of the Companies Act 2006 relating to small companies.

The members have not required the company to obtain an audit in accordance with section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These accounts have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

This report was approved by the board of directors on 7 September 2024
And Signed On Behalf Of The Board By:

Name: Mr B L Parsons
Status: Director

The notes form part of these financial statements

ESSINGTON CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

  • 1. Accounting policies

    Basis of measurement and preparation

    These financial statements have been prepared in accordance with the provisions of Section 1A (Small Entities) of Financial Reporting Standard 102

    Turnover policy

    Turnover is recognised at the fair value of the consideration received or receivable for goods and services provided in the normal course of business, and is shown net of VAT and other sales related taxes. The fair value of consideration takes into account trade discounts, settlement discounts and volume rebates.

    Tangible fixed assets depreciation policy

    Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

    Depreciation is recognised so as to write off the cost or valuation of assets less their residual value over their useful lives on the following basis:
    Improvements to property - 10% straight line
    Computer equipment - 25% straight line
    Fixtures and fittings - 15% reducing balance
    Plant and machinery - 15% reducing balance

ESSINGTON CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

  • 2. Employees


    2023

    2022
    Average number of employees during the period 5 4

ESSINGTON CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

  • 3. Off balance sheet disclosure

    No

ESSINGTON CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

4. Intangible assets

Goodwill Total
Cost £ £
At 01 January 2023 225,000 225,000
Additions - -
Disposals ( 225,000 ) ( 225,000 )
Revaluations - -
Transfers - -
At 31 December 2023 0 0
Amortisation
Amortisation at 01 January 2023 225,000 225,000
Charge for year - -
On disposals ( 225,000 ) ( 225,000 )
Other adjustments - -
Amortisation at 31 December 2023 0 0
Net book value
Net book value at 31 December 2023 0 0
Net book value at 31 December 2022 0 0

ESSINGTON CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

5. Tangible assets

Land & buildings Plant & machinery Fixtures & fittings Office equipment Total
Cost £ £ £ £ £
At 01 January 2023 17,496 20,159 14,505 17,365 69,525
Additions 2,700 - - - 2,700
Disposals - ( 13,491 ) - - ( 13,491 )
Revaluations - - - - -
Transfers - - - - -
At 31 December 2023 20,196 6,668 14,505 17,365 58,734
Depreciation
At 01 January 2023 17,496 14,367 13,263 17,203 62,329
Charge for year 270 869 186 81 1,406
On disposals - ( 9,261 ) - - ( 9,261 )
Other adjustments - - - - -
At 31 December 2023 17,766 5,975 13,449 17,284 54,474
Net book value
At 31 December 2023 2,430 693 1,056 81 4,260
At 31 December 2022 0 5,792 1,242 162 7,196

ESSINGTON CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

6. Debtors


2023
£

2022
£
Other debtors 40,118 0
Total 40,118 0

ESSINGTON CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

7.Creditors: amounts falling due within one year note


2023
£

2022
£
Bank loans and overdrafts 7,600 7,500
Taxation and social security 15,972 5,634
Accruals and deferred income 375 3,112
Total 23,947 16,246

ESSINGTON CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

8.Creditors: amounts falling due after more than one year


2023
£

2022
£
Bank loans and overdrafts 11,774 19,239
Total 11,774 19,239

ESSINGTON CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

9.1. Loans to Directors

Name of director receiving advance or credit: Mr B L Parsons
Description of the transaction:
loan to director
Balance at 01 January 2023 0
Advances or credits made: 30,852
Advances or credits repaid: 17,442
Balance at 31 December 2023 13,410

Name of director receiving advance or credit: Mrs T L Parsons
Description of the transaction:
Loan to director
Balance at 01 January 2023 0
Advances or credits made: 30,283
Advances or credits repaid: 16,929
Balance at 31 December 2023 13,354

ESSINGTON CLINIC LIMITED

Notes to the Financial Statements

for the Period Ended 31 December 2023

9.2. Loans to Directors

Name of director receiving advance or credit: Mr Z C Cole
Description of the transaction:
Loan to director
Balance at 01 January 2023 0
Advances or credits made: 30,283
Advances or credits repaid: 16,929
Balance at 31 December 2023 13,354